Pseudomonas vaccine - ID Biomedical/Millenium Biologix
Alternative Names: Cytovaxine; SPD-705Latest Information Update: 02 Jun 2010
At a glance
- Originator Millenium Biologix Corporation
- Class Bacterial vaccines; Pseudomonas vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pseudomonal infections
Most Recent Events
- 06 Dec 2004 Millenium Biologix has merged with Cytovax Biotechnologies to form Millenium Biologix Corporation
- 27 Oct 2004 Cytovaxine™ is available for licensing (http://www.cytovax.com)
- 27 Oct 2004 Cytovaxine™ is no longer licensed to ID Biomedical Corporation